|
HY-100320-1mg
|
MedChemexpress LLC
|
AVE5688 [CAS 613260-13-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100714-10mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-100714-25mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-100714-5mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-100714-50mg
|
MedChemexpress LLC
|
DL-AP5 [CAS 76326-31-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-101054-10mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101054-100mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101054-25mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101054-5mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101054-50mg
|
MedChemexpress LLC
|
NQ301 [CAS 130089-98-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101056-10mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101056-100mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101056-5mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101056-50mg
|
MedChemexpress LLC
|
Brensocatib [CAS 1802148-05-5]
|
|
COVID-19-immunoregulation
|
|
|
HY-101250-10mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-100mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-25mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-5mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101250-50mg
|
MedChemexpress LLC
|
Glemanserin [CAS 107703-78-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-101381-1mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-10mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-100mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-25mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-5mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-101381-50mg
|
MedChemexpress LLC
|
Otenzepad [CAS 102394-31-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
